Screening for multiple cancers is now possible with Galleri®

Alignment Health Plan partnered with GRAIL to offer its Medicare Advantage members access to the Galleri multi-cancer early detection test for a $75 copay. Through a simple blood draw, Galleri screens for a signal shared by more than 50 types of cancer.1 Eligible Alignment Health Plan members can request one test every two years.*

Check Eligibility and Request the Test

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. Galleri should be used in addition to healthcare provider recommended screening tests.

Galleri Lifestyle Shot10 4043

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. Galleri should be used in addition to healthcare provider recommended screening tests.

Key benefits of the Galleri test

blue circle graphic with a magnifying glass icon with illustrated cancer cells in the center

Screen for more cancers

Added to recommended screening, the Galleri test improves your chance to find cancer early. It detects a signal shared by dozens of cancers including many that don't have screening tests.1

blue circle illustrated graphic with a test tube icon inside

Testing with ease

Screen with a simple blood draw easily added to your cancer screening plan.

No fasting or preparation required.

Test requires a prescription from a telemedicine provider

blue circle graphic with icon indicating test results inside

Proactive health information

If a signal is found, results predict the tissue type or organ associated with the cancer signal to help your healthcare provider guide next steps.1

The Galleri test looks for a signal associated with active cancer and does not predict your future genetic risk for cancer. Diagnostic testing is needed to confirm cancer. False positive and false negative results do occur.

Our testing process

illustrated graphic of a Black male doctor in a white lab coat reading a chart

Request the test

Get started by creating a Galleri portal account and completing an online test request which includes questions about your medical history (about 10 minutes).
illustrated graphic of the Galleri test box sitting on a table in front of a window

Receive a collection kit

An independent telemedicine provider from Recuro Health will review your request, confirm your eligibility, and order the test if appropriate. You can schedule a blood draw at a GRAIL blood draw partner and we will ship you a Galleri collection kit for your appointment.

illustrated graphic of a white, gray haired female patient having her blood drawn

Provide your sample

The trained technician that draws your blood sample will ship the kit to the GRAIL lab.

Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

Receive your results

Recuro Health will reach out when your results are ready - about 2 weeks after your blood is received at the GRAIL laboratory. Your test result will be shared with you by Recuro Health.

What is the Galleri test?

Galleri is the first-of-its-kind multi-cancer early detection test—a test that looks for a signal shared by more than 50 types of cancer with a single blood test. It is a screening test and does not diagnose cancer, further testing is required to confirm cancer.

About the test
About the results
illustrated video poster of the Galleri test sitting on a table in an examination room with an anatomy poster on the wall behind it

Frequently Asked Questions for Alignment

Additional Frequently Asked Questions about the Galleri test

Alignment Health plan members enrolled in the following plans are eligible to request the Galleri test: 

Arizona

  • Alignment Health the ONE + Walgreens (HMO)/ Alignment Health el ÚNICO + Walgreens (HMO) 001
  • Alignment Health the ONE + Walgreens (HMO)/ Alignment Health el ÚNICO + Walgreens (HMO) 002

California

  • Alignment Health Platinum + Instacart (HMO) 008
  • Alignment Health Platinum + Instacart (HMO-POS) 016
  • Alignment Health Balance (HMO C-SNP) 033
  • Alignment Health Balance (PPO) 006
  • Alignment Health Advantage PPO (PPO) 001
  • Alignment Health Advantage PPO (PPO) 002

Nevada 

  • Alignment Health Platinum + Instacart (HMO) 007
  • Alignment Health + Intermountain (HMO) 009

North Carolina

  • Alignment Health Platinum (HMO) 003
  • Alignment Health Platinum Select (HMO) 010

Texas

  • Alignment Health the ONE + Walgreens (HMO-POS) / Alignment Health el ÚNICO + Walgreens (HMO-POS) 001

Eligible members can receive one Galleri test every two years with a $75 copay.

If you choose to complete the blood draw at another lab, including your primary healthcare provider’s office, you will be responsible for the blood draw fee.

No, eligible members must request the test through Recuro Health, an independent telemedicine healthcare provider, via the test request process through this link Galleri.com/partner/alignment.

When you request the test, you are given the option to enter your primary healthcare provider’s contact information; if you provide this, your test result will be automatically shared with your primary healthcare provider if a cancer signal is detected. If no cancer signal is detected, you can share the results with your provider, but GRAIL will not automatically send it.

Family history is only one of many risk factors associated with cancer development. Other risk factors include eating habits, lifestyle, living or working environments, genetics, and many others.

When you submit your test request, you may ask for a pre-test consultation with a Recuro Health telemedicine provider to discuss whether the test is right for you. This optional consultation is included in the benefit.

Get support

For questions about the Galleri test, please contact GRAIL Customer Service:

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI:https://doi.org/10.1016/j.annonc.2021.05.806.